Shanghai Mayor Gong Zheng met today with Long Haige, Chairman of the Board of Directors of Denmark's Novo Nordisk. He stated that Shanghai will continue to enhance its capacity to drive scientific and technological innovation in the biopharmaceutical industry, further promote the industry's international development, and accelerate the development of a globally influential biopharmaceutical innovation hub. He welcomed the active participation of world-renowned companies such as Novo Nordisk, who are committed to continuously upgrading their Shanghai headquarters, deeply integrating into the local R&D and supply chains, empowering Shanghai-based companies and medical research institutions, and supporting the development of Shanghai's biopharmaceutical industry to achieve mutually beneficial cooperation. He also welcomed Novo Nordisk's active participation in the 8th China International Import Expo (CIIE). Shanghai will continue to foster a first-class business environment that is market-oriented, law-based, and internationalized, providing better conditions for the development of all types of business entities.